Assessment of Agent-Based Tobacco Models
The committee report was released in March 2015. For more information on the report and access to the free report pdf, please see the link at the right of the page.
For this project, sponsored by the U.S. Food and Drug Administration (FDA), the Institute of Medicine (IOM) convened a committee to assess the applicability of agent-based models of tobacco use and public health as a guide to inform regulators and improve the effect of tobacco regulation policies on public health. Below is the committee's statement of task.
The committee shall:
• comment on implications of using agent-based models to examine various tobacco regulatory policies
• assess the strengths and weaknesses of a agent-based model developed for the FDA (to be provided by Center for Tobacco Products [CTP]) and models currently available in the literature that have been used for similar purposes (to be identified by the CTP)
• make recommendations on future directions and strategies to improve the usefulness of the model developed for or to be used by the FDA, if needed.
For more information